Literature DB >> 9200447

Bcl-2 expression in target cells leads to functional inhibition of caspase-3 protease family in human NK and lymphokine-activated killer cell granule-mediated apoptosis.

C Renvoizé1, R Roger, N Moulian, J Bertoglio, J Bréard.   

Abstract

In the granule exocytosis pathway of cell-mediated cytotoxicity, rapid apoptotic nuclear damage in target cells has been unequivocally linked to granzyme B activity. Direct cleavage and activation of caspase-3 and related proteases by granzyme B have been identified as a central event in apoptosis induction by cytotoxic granules. The Bcl-2 oncoprotein has been recently shown to act at the level or upstream of caspase-3 family activation to inhibit apoptosis induced by various stimuli including Fas ligation, an alternative cell-mediated lytic pathway. In this study, we have investigated whether activation of this caspase family by granzyme B, during human NK and lymphokine-activated killer cell granule-mediated apoptosis, could be influenced by Bcl-2 expression. Bcl-2-overexpressing clones were generated from parental K562 and U937 cell lines (K6 and U4 clones, respectively). Bcl-2 expression abrogated early 125I-DNA release and DNA fragmentation, these defects being compensated for by extended incubation times. Cleavage of poly(ADP-ribose) polymerase, a specific caspase-3 family substrate, was detected in parental K562 cells exposed to lymphokine-activated killer effectors but not in K6 targets, indicating that caspase-3 and related proteases function was inhibited by Bcl-2. Functional inhibition of caspase-3 family with benzyloxycarbonyl-Asp-Glu-Val-Asp(OMe) fluoromethylketone led to similar consequences on apoptotic nuclear events as for Bcl-2 expression. Thus, Bcl-2 antagonizes granzyme B-mediated apoptosis by a mechanism that interferes with caspase-3 activity. Finally, Bcl-2 expression or the Asp-Glu-Val-Asp peptide was much less efficient in preventing phosphatidylserine externalization, suggesting that despite impaired nuclear apoptosis, immediate recognition and elimination of Bcl-2-expressing cells by tissue phagocytes should remain partly unaffected.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9200447

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.

Authors:  X M Zhang; H Lin; C Chen; B D Chen
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  c-Myc regulates expression of NKG2D ligands ULBP1/2/3 in AML and modulates their susceptibility to NK-mediated lysis.

Authors:  Arash Nanbakhsh; Cécile Pochon; Aude Mallavialle; Sophie Amsellem; Jean Henri Bourhis; Salem Chouaib
Journal:  Blood       Date:  2014-03-27       Impact factor: 22.113

3.  E1B 19,000-molecular-weight protein interacts with and inhibits CED-4-dependent, FLICE-mediated apoptosis.

Authors:  J Han; H D Wallen; G Nuñez; E White
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

4.  miR-181a modulates acute myeloid leukemia susceptibility to natural killer cells.

Authors:  Arash Nanbakhsh; Géraldine Visentin; Daniel Olive; Bassam Janji; Eugenie Mussard; Philippe Dessen; Guillaume Meurice; Yanyan Zhang; Fawzia Louache; Jean-Henri Bourhis; Salem Chouaib
Journal:  Oncoimmunology       Date:  2015-10-16       Impact factor: 8.110

5.  Direct cleavage of ROCK II by granzyme B induces target cell membrane blebbing in a caspase-independent manner.

Authors:  Michael Sebbagh; Jocelyne Hamelin; Jacques Bertoglio; Eric Solary; Jacqueline Bréard
Journal:  J Exp Med       Date:  2005-02-07       Impact factor: 14.307

6.  rTMS alleviates AD-induced cognitive impairment by inhibitng apoptosis in SAMP8 mouse.

Authors:  Zheng Bao; Li Bao; Na Han; Yueyun Hou; Fumin Feng
Journal:  Aging (Albany NY)       Date:  2021-12-29       Impact factor: 5.682

7.  Mitochondria-dependent and -independent regulation of Granzyme B-induced apoptosis.

Authors:  G MacDonald; L Shi; C Vande Velde; J Lieberman; A H Greenberg
Journal:  J Exp Med       Date:  1999-01-04       Impact factor: 14.307

Review 8.  Unleashing the power of NK cells in anticancer immunotherapy.

Authors:  Meike Vogler; Senthan Shanmugalingam; Vinzenz Särchen; Lisa Marie Reindl; Victoria Grèze; Leon Buchinger; Michael Kühn; Evelyn Ullrich
Journal:  J Mol Med (Berl)       Date:  2021-08-09       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.